Frazier Healthcare Partners welcomes Willis Chandler as Executive in Residence
Frazier Healthcare Partners, a private equity firm dedicated solely to healthcare, has added a new voice to its Growth Buyout team. Willis Chandler, a seasoned leader with deep experience in pharmaceuticals, has joined the firm as an Executive in Residence. The move underscores Frazier’s continued focus on building and scaling businesses across the healthcare ecosystem.
A focused mandate in pharma and pharmacy services
In this role, Chandler will work side by side with Frazier to shape and execute investment strategies across pharma and pharmacy services. He’ll help source, evaluate, and lead new platform investments—core engines for the firm’s growth plans and a key way the team builds companies with long-term potential.
Chandler’s vision for growth
Chandler put it plainly: “I have long admired the way Frazier’s Growth Buyout team approaches sourcing and growing promising healthcare companies. I am excited to work alongside Frazier to identify and engage with disruptive, growth-oriented healthcare companies.” His perspective tracks with Frazier’s aim to back innovation and scale it with discipline.
Experience that matters
Chandler joins Frazier after serving as President of Global Pharma Services at Cencora, previously known as Amerisource Bergen. There, he led a multi-billion dollar business that employed about 10,000 people, guiding complex operations at scale. That chapter sits alongside a broader career spent leading teams and businesses across healthcare and pharma.
Leadership experience and achievements
Before Cencora, Chandler held senior posts including President of Health System, Specialty, Government, and Commercial Solutions, where he set direction for distribution and service offerings to health systems and specialty sites of care. Earlier, he served as VP of Health System Alliances at CVS Health and co-founded Shields Specialty Pharmacy, a company focused on pharmacy services for hospitals and health systems.
Across these roles, Chandler built a track record in entrepreneurial leadership, commercial transformation, and integrating acquisitions. That blend—starting, scaling, and stitching businesses together—aligns with Frazier Healthcare Partners’ mission and the needs of its portfolio.
About Frazier Healthcare Partners
Founded in 1991, Frazier Healthcare Partners is a healthcare-focused private equity firm with a long-standing presence in the sector. Over its 32 years of operation, the firm has raised beyond $8 billion in capital for private funds and co-investments and has supported more than 200 companies. Frazier’s playbook centers on partnering with outstanding management teams and putting the firm’s operating resources and network to work to build standout healthcare companies.
A bright future ahead
Headquartered in Seattle, Frazier Healthcare Partners invests across the United States, Canada, and Europe. With its ongoing commitment to healthcare innovation—and a team built for growth—the firm remains a leader within healthcare-focused private equity.
Frequently Asked Questions
Who is Willis Chandler?
Willis Chandler is the new Executive in Residence at Frazier Healthcare Partners. He’s a veteran pharma executive who most recently served as President of Global Pharma Services at Cencora (previously Amerisource Bergen), where he led a multi-billion dollar business with about 10,000 employees.
What will Chandler do in this role?
He’ll work with Frazier’s Growth Buyout team to develop and execute investment strategies in pharma and pharmacy services, with a focus on sourcing and leading new platform investments.
How does Chandler’s background fit Frazier’s approach?
His experience in building businesses, driving commercial change, and integrating acquisitions mirrors Frazier’s focus on partnering with strong management teams and using operating resources to scale healthcare companies.
Where does Frazier Healthcare Partners invest?
The firm is headquartered in Seattle, WA, and maintains an active investment footprint across the U.S., Canada, and Europe.
How experienced is Frazier in healthcare investing?
Since 1991, Frazier has operated exclusively in healthcare, raising beyond $8 billion in capital for private funds and co-investments and supporting more than 200 companies over its 32 years.
